ClinicalTrials.govpublic full text
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
cardiovascular disease, cardiovascular outcomes, heart attack, stroke, drug therapy, physiology, hyperuricemia, uric acid, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 993552
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.